chrX-133536151-C-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_004484.4(GPC3):​c.1716G>C​(p.Val572Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000423 in 1,205,276 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 18 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., 2 hem., cov: 21)
Exomes 𝑓: 0.000039 ( 0 hom. 16 hem. )

Consequence

GPC3
NM_004484.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.69

Publications

0 publications found
Variant links:
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
  • Simpson-Golabi-Behmel syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Simpson-Golabi-Behmel syndrome type 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant X-133536151-C-G is Benign according to our data. Variant chrX-133536151-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 476652.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.69 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0000725 (8/110407) while in subpopulation NFE AF = 0.000151 (8/52888). AF 95% confidence interval is 0.0000748. There are 0 homozygotes in GnomAd4. There are 2 alleles in the male GnomAd4 subpopulation. Median coverage is 21. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GPC3NM_004484.4 linkc.1716G>C p.Val572Val synonymous_variant Exon 8 of 8 ENST00000370818.8 NP_004475.1 P51654-1Q53H15I6QTG3
GPC3NM_001164617.2 linkc.1785G>C p.Val595Val synonymous_variant Exon 9 of 9 NP_001158089.1 P51654-3Q53H15
GPC3NM_001164618.2 linkc.1668G>C p.Val556Val synonymous_variant Exon 8 of 8 NP_001158090.1 Q53H15B4DTD8
GPC3NM_001164619.2 linkc.1554G>C p.Val518Val synonymous_variant Exon 7 of 7 NP_001158091.1 P51654-2Q53H15

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GPC3ENST00000370818.8 linkc.1716G>C p.Val572Val synonymous_variant Exon 8 of 8 1 NM_004484.4 ENSP00000359854.3 P51654-1

Frequencies

GnomAD3 genomes
AF:
0.0000725
AC:
8
AN:
110407
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000151
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000546
AC:
10
AN:
183110
AF XY:
0.0000739
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000122
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000393
AC:
43
AN:
1094869
Hom.:
0
Cov.:
30
AF XY:
0.0000443
AC XY:
16
AN XY:
360845
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26329
American (AMR)
AF:
0.00
AC:
0
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19366
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54041
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40494
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3307
European-Non Finnish (NFE)
AF:
0.0000500
AC:
42
AN:
840009
Other (OTH)
AF:
0.0000218
AC:
1
AN:
45921
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000725
AC:
8
AN:
110407
Hom.:
0
Cov.:
21
AF XY:
0.0000613
AC XY:
2
AN XY:
32601
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30322
American (AMR)
AF:
0.00
AC:
0
AN:
10313
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2637
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3515
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2500
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5830
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
233
European-Non Finnish (NFE)
AF:
0.000151
AC:
8
AN:
52888
Other (OTH)
AF:
0.00
AC:
0
AN:
1484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000216
Hom.:
1
Bravo
AF:
0.0000604
EpiCase
AF:
0.000327
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Wilms tumor 1 Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
2.7
DANN
Benign
0.60
PhyloP100
2.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779688123; hg19: chrX-132670179; API